Stimulation of proximal tubular cell apoptosis by albumin-bound fatty acids mediated by peroxisome proliferator activated receptor-γ

Journal of the American Society of Nephrology

Volumn 14, Issue 1, 2003, Pages 17-27

  Arici, Mustafa ^a   Chana, Ravinder ^a   Lewington, Andrew ^a   Brown, Jez ^a   Brunskill, Nigel John ^a  

^a UNIVERSITY OF LEICESTER   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ALBUMIN; DNA; ETOPOSIDE; FATTY ACID; NICOTINAMIDE ADENINE DINUCLEOTIDE ADENOSINE DIPHOSPHATE RIBOSYLTRANSFERASE; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR ALPHA; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR DELTA; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR GAMMA; PROSTAGLANDIN J2; RETINOID X RECEPTOR;

APOPTOSIS; ARTICLE; CELL DEATH; CELL PROLIFERATION; CONTROLLED STUDY; DOSE RESPONSE; GENE EXPRESSION; HUMAN; HUMAN CELL; IMMUNOBLOTTING; KIDNEY DISEASE; KIDNEY PROXIMAL TUBULE; NEPHROTIC SYNDROME; PRIORITY JOURNAL; PROTEINURIA;

EID: 9644254466     PISSN: 10466673     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.ASN.0000042167.66685.EA     Document Type: Article

References (53)

1. Cameron JS, Turner DR, Ogg CS, Chantler C, Williams DG: The long-term prognosis of patients with focal segmental glomerulosclerosis. Clin Nephrol 10: 213-218, 1978
2. Cameron JS: Proteinuria and progression in human glomerular disease. Am J Nephrol 10[Suppl 1] 81-87, 1990
3. Risdon RA, Sloper JC, De Wardener HE: Relationship between renal function and histological changes found in renal-biopsy specimens from patients with persistent glomerular nephritis. Lancet 1: 363-366, 1968
4. Thomas ME, Brunskill NJ, Harris KPG, Bailey E, Pringle JH, Furness PN, Walls J: Proteinuria induces tubular cell turnover: A potential mechanism for tubular atrophy. Kidney Int 55: 890- 898, 1999
5. Hebert LA, Agarwal G, Sedmak DD, Mahan JD, Becker W, Nagaraja HN: Proximal tubular epithelial hyperplasia in patients with chronic glomerular proteinuria. Kidney Int 57: 1962, 1967, 2000
6. Brunskill NJ, Tobin A, Nahorski S, Walls J: Receptor-medicated endocytosis of albumin by kidney proximal tubule cells is regulated by phosphatidylinositide 3-kinase. J Clin Invest 101: 2140-2150, 1998
7. Dixon R, Brunskill NJ: Activitation of mitogenic pathways by albumin in kidney proximal tubular cells: Implications for proteinuric states. J Am Soc Nephrol 10: 1487-1497, 1999
8. Dixon R, Brunskill NJ: Albumin stimulates p44/p42 extracellular signal regulated MAP kinase in opossum kidney proximal tubular cells. Clin Sci 98: 295-301, 2000
9. Wang T, Rangan GK, Tay YC, Rangan GK, Harris, DC: Induction of monocyte chemoattractant protein-1 by albumin is mediated by nuclear factor-κB in proximal tubule cells. J Am Soc Nephrol 10: 1204-1213, 1999
10. Zoja C, Donadelli R, Colleoni S, Figliuzzi M, Bonazzola S, Morigi M, Remuzzi G: Protein overload stimulates RANTES production by proximal tubular cells depending on NF-κB activation. Kidney Int 53: 1608-1615, 1998
11. 1 cells. Am J Physiol 280: F1107-F1114, 2001
12. Iglesias J, Abernethy VE, Wang Z, Lieberthal W, Koh JS, Levine JS: Albumin is a major serum survival factor for renal tubular cells and macrophages through scavenging of ROS. Am J Physiol 277: F711-F722, 1999
13. Ghiggeri GM, Ginevri F, Candiano G, Oleggini R, Perfumo F, Queirolo C, Gusmano R: Characterization of cationic albumin in minimal change nephropathy. Kidney Int 32: 547-53, 1987
14. Fried LF, Orchard TJ, Kasiske BL: Effect of lipid reduction on the progression of renal disease: A meta-analysis. Kidney Int 59: 260-269, 2001
15. Hamilton JA, Era S, Bhamidipati SP, Reed RG: Location of the three primary binding sites for long-chain fatty acids on bovine serum albumin. Proc Natl Acad Sci USA 88: 2051-2054, 1991
16. Spector AA: Plasma albumin as a lipoprotein. In: Biochemistry and Biology of Plasma Lipoproteins. Volume II: The Biochemistry of Disease, edited by Scanu AM, Spector AA, New York, Marcel Dekker, 1986, pp 247-279
17. Shafrir E: Partition of unesterified fatty acids in normal and nephrotic serum and its effect on serum electrophoretic pattern. J Clin Invest 37: 1775, 1958
18. Thomas ME, Morrison AR, Schreiner GF: Metabolic effects of fatty acid-bearing albumin on a proximal tubule cell line. Am J Physiol 268: F1177-F1184, 1995
19. Kees-Folts D, Sadow JL, Schreiner GF: Tubular catabolism of albumin is associated with the release of an inflammatory lipid. Kidney Int 45: 1697-1709, 1994
20. Schoonjans K, Staels B, Auwerx J: The peroxisome proliferator activated receptors (PPARS) and their effects on lipid metabolism and adipocyte differentiation. Biochim Biophys Acta 1302: 93-109, 1996
21. Willson TM, Lambert MH, Kliewer SA: Peroxisome proliferator-activated receptor-γ and metabolic disease. Annu Rev Biochem 70: 341-367, 2001
22. Kliewer SA, Forman BM, Blumberg B, Ong ES, Borgmeyer U, Mangelsdorf DJ, Umesono K, Evans RM: Differential expression and activation of a family of murine peroxisome proliferator-activated receptors. Proc Natl Acad Sci USA 91: 7355-7359, 1994
23. Vidal-Puig AJ, Considine RV, Jimenez-Linan M, Werman A, Pories WJ, Caro JF, Flier JS: Peroxisome proliferator-activated receptor gene expression in human tissues. Effects of obesity, weight loss, and regulation by insulin and glucocorticoids. J Clin Invest 99: 2416-2422, 1997
24. Auboeuf D, Rieusset J, Fajas L, Vallier P, Frering V, Riou JP, Staels B, Auwerx J, Laville M, Vidal H: Tissue distribution and quantification of the expression of mRNAs of peroxisome proliferator-activated receptors and liver X receptor-alpha in humans: No alteration in adipose tissue of obese and NIDDM patients. Diabetes 46: 1319-1327, 1997
25. Guan Y, Zhang Y, Davis L, Breyer MD: Expression of peroxisome proliferator-activated receptors in urinary tract of rabbits and humans. Am J Physiol 273: F1013-F1022, 1997
26. Yang T, Michele DE, Park J, Smart AM, Lin Z, Brosius FC III, Schnermann JB, Briggs JP: Expression of peroxisomal proliferator-activated receptors and retinoid X receptors in the kidney. Am J Physiol 277: F966-F973, 1999
27. Kliewer SA, Umesono K, Noonan DJ, Heyman RA, Evans RM: Convergence of 9-cis retinoic acid and peroxisome proliferator signalling pathways through heterodimer formation of their receptors. Nature 358: 771-774, 1992
28. Leone TC, Weinheimer CJ, Kelly DP: A critical role for the peroxisome proliferator-activated receptor-α (PPARα) in the cellular fasting response: The PPARα-null mouse as a model of fatty acid oxidation disorders. Proc Natl Acad Sci USA 96: 7473-7478, 1999
29. Kliewer SA, Lenhard JM, Willson TM, Patel I, Morris DC, Lehmann JM: A prostaglandin J2 metabolite binds peroxisome proliferator-activated receptor-γ and promotes adipocyte differentiation. Cell 83: 813-819, 1995
30. Chinetti G, Griglio S, Antonucci M, Torra IP, Delerive P, Majd Z, Fruchart JC, Chapman J, Najib J, Staels B: Activation of proliferator-activated receptors α and γ induces apoptosis of human monocyte-derived macrophages. J Biol Chem 273: 25573-25580, 1998
31. 2. J Biol Chem 274: 17042-17048, 1999
32. Takahashi N, Okumura T, Motomura W, Fujimoto Y, Kawabata I, Kohgo Y: Activation of PPAR inhibits cell growth and induces apoptosis in human gastric cancer cells. FEBS Lett 455: 135-139, 1999
33. Altoik S, Xu M, Spiegelman BM: PPARγ induces cell cycle withdrawal: Inhibition of E2F/DP DNA-binding activity via down-regulation of PP2A: Genes Dev 11: 1987-1998, 1997
34. Guan Y, Breyer MD: Peroxisome proliferator-activated receptors (PPARs): Novel therapeutic targets in renal disease. Kidney Int 60: 14-30, 2001
35. Burton CJ, Combe C, Walls J, Harris KPG: Fibronectin production by human tubular cells: The effect of apical protein. Kidney Int 50: 760-767, 1996
36. Detrisac CJ, Sens MA, Garvin AJ, Spicer SS, Sens DA: Tissue culture of human kidney epithelial cells of proximal tubule origin. Kidney Int 25: 383-390, 1984
37. Mooney A, Jackson K, Bacon R, Streuli C, Edwards G, Bassuk J, Savill J: Type IV collagen and laminin regulate glomerular mesangial cell susceptibility to apoptosis via β(1) integrin-mediated survival signals. Am J Pathol 155: 599-606, 1999
38. Palmer CNA, Hsu M-HH, Griffin KJ, Johnson EF: Novel sequence determinants in peroxisome proliferator signalling. J Biol Chem 270: 16114-16121, 1995
39. rd ed, Boston, Little, Brown, 1983, pp 617-724
40. Goodman DS: The interaction of human serum albumin with long chain fatty acid anions. J Am Chem Soc 80: 3892-3898, 1958
41. Saifer A, Goldman L: The free fatty acids bound to human serum albumin. J Lipid Res 2: 268-270, 1961
42. Thomas ME, Schreiner GF: Contribution of proteinuria to progressive renal injury: Consequences of tubular uptake of fatty acid bearing albumin. Am J Nephrol 13: 385-398, 1993
43. Lewy JE, Pesce A: Micropuncture study of albumin transfer in aminonucleoside nephrosis in the rat. Pediatr Res 7: 553-559, 1973
44. Thomas ME, Harris KPG, Walls J, Furness PN, Brunskill NJ: Fatty acids exacerbate tubulointerstitial injury in protein-overload proteinuria. Am J Physiol 2002, in press
45. McCarthy KJ, Routh RE, Shaw W, Walsh K, Welbourne TC, Johnson JH: Troglitazone halts diabetic glomerulosclerosis by blockade of mesangial expansion. Kidney Int 58: 2341-2350, 2000
46. Asano T, Wakisaka M, Yoshinari M, Iino K, Snoki K, Iwase M, Fujishima M: Peroxisome proliferator-activated receptor γ 1 (PPAR-γ-1) expresses in rat mesangial cells and PPARγ agonists modulate its differentiation. Biochim Biophys Acta 1497: 148-154, 2000
47. Nicholas SB, Kawano Y, Wakino S, Collins AR, Hsueh WA: Expression and function of peroxisome proliferator-activated receptor-γ in mesangial cells. Hypertension 37: 722-727, 2001
48. Ma LJ, Marcantoni C, Linton MF, Fazio S, Fogo AB: Peroxisome proliferator-activated receptor-γ agonist troglitazone protects against nondiabetic glomerulosclerosis in rats. Kidney Int 59: 1899-1910, 2001
49. Adams M, Montague CT, Prins JB, Holder JC, Smith SA, Sanders L, Digby JE, Sewter CP, Lazar MA, Chatterjee VK, O'Rahilly S: Activators of peroxisome proliferator-activated receptor-γ have depot-specific effects on human preadipocyte differentiation. J Clin Invest 100: 3149-3153, 1997
50. Wiesenberg I, Chiesi M, Missbach M, Spanka C, Pignat W, Carlberg C: Specific activation of the nuclear receptors PPAR and RORA by the antidiabetic thiazolidinedione BRL 49653 and the antiarthritic thiazolidinedione derivative CGP 52608. Mol Pharmacol 53: 1131-1138, 1998
51. Reginato MJ, Bailey ST, Krakow SL, Minami C, Ishii S, Tanaka H, Lazar MA: A potent antidiabetic thiazolidinedione with unique peroxisome proliferator-activated receptor γ-activating properties. J Biol Chem 273: 32679-32684, 1998
52. Camp HS, Li O, Wise SC, Hong YH, Frankowski CL, Shen X, Vanbogelen R, Leff T: Differential activation of peroxisome proliferator-activated receptor-γ by troglitazone and rosiglitazone. Diabetes 49: 539-47, 2000
53. Kodera Y, Takeyama K, Murayama A, Suzawa M, Masuhiro Y, Kato S: Ligand type-specific interactions of peroxisome proliferator-activated receptor-γ with transcriptional coactivators. J Biol Chem 275: 33201-33204, 2000